0001144204-17-065938.txt : 20171229
0001144204-17-065938.hdr.sgml : 20171229
20171229172544
ACCESSION NUMBER: 0001144204-17-065938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171208
FILED AS OF DATE: 20171229
DATE AS OF CHANGE: 20171229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schreck Edward
CENTRAL INDEX KEY: 0001572822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37392
FILM NUMBER: 171282741
MAIL ADDRESS:
STREET 1: 700 NORTH BRAND BLVD.
STREET 2: SUITE 450
CITY: GLENDALE
STATE: CA
ZIP: 91203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc.
CENTRAL INDEX KEY: 0001083446
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 870042699
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 700 NORTH BRAND BLVD.,
STREET 2: SUITE 1400
CITY: GLENDALE
STATE: CA
ZIP: 91203
BUSINESS PHONE: 818-839-5200
MAIL ADDRESS:
STREET 1: 700 NORTH BRAND BLVD.,
STREET 2: SUITE 1400
CITY: GLENDALE
STATE: CA
ZIP: 91203
FORMER COMPANY:
FORMER CONFORMED NAME: SICLONE INDUSTRIES INC
DATE OF NAME CHANGE: 19990413
4
1
tv481458_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-12-08
1
0001083446
Apollo Medical Holdings, Inc.
AMEH
0001572822
Schreck Edward
700 N. BRAND BLVD.
SUITE 1400
GLENDALE
CA
91203
0
0
0
1
Former Director
Stock Option (right to buy)
5
2016-10-14
2026-09-14
Common Stock, par value $0.001 per share
20000
140000
D
Stock Option (right to buy)
5.79
2016-03-15
2026-02-14
Common Stock, par value $0.001 per share
20000
140000
D
Stock Option (right to buy)
0.145
2012-02-01
2022-02-01
Common Stock, par value $0.001 per share
100000
140000
D
This form is not filed to reflect any transactions but to disclose that Reporting Person resigned from the board of directors of Apollo Medical Holdings, Inc. ("ApolloMed"), effective as of the closing of a merger between Apollo Acquisition Corp., a wholly owned subsidiary of ApolloMed, and Network Medical Management, Inc., a California corporation, on December 8, 2017, and as a result, is no longer subject to Section 16, Form 4 or Form 5 obligations based on his directorship at ApolloMed.
The option vested at the rate of one-twelfth of the shares per month commencing on October 14, 2016.
The option vested at the rate of one-twelfth of the shares per month commencing on March 15, 2016.
The option vested at the rate of one-third of the shares per year commencing on February 1, 2012.
As of December 8, 2017, Reporting Person had direct ownership of stock options with respect to 140,000 shares of common stock of ApolloMed.
/s/ Edward Schreck
2017-12-28